期刊文献+

非上皮性肿瘤组织中CD117、CD34的表达 被引量:1

Expressions of CD117 and CD34 in non-epithelial tumours
下载PDF
导出
摘要 目的:探讨胃肠道间质瘤的诊断和免疫组化结果。方法:收集我院1995~2005年手术切除的胃肠道非上皮性肿瘤存档的36份病例进行研究。结果:典型的平滑肌和神经来源的肿瘤CD117和CD34阴性,间质瘤是Desmin和Actin阳性反应以外CD117、CD34均为阳性表达,神经来源的肿瘤NSE和S-100均阳性表达。结论:间质瘤(GIST)是消化道最常见的间叶源性肿瘤,间质瘤的生物学特点与胃肠平滑肌瘤和神经鞘瘤不同,免疫组化常表达CD117、CD34。 Objective: To discuss the gastrointestinal stromal diagnosis and the results of immunohistochemistry. Methods: Thirty six cases of archival which were the surgical resection of gastrointestinal non-epithelial tumors in 1995-2005 in our Hospital were researched. Results: In the typical smooth muscle and nerve tumor, CDl17 and CD34 were negative. Positive expressions of CD117 and CD34, were found is gastrointestinal stromal tumours as well as the expression of Desmin and Actin. The neural tumor could be expressed with NSE and S 100. Conclusion: Gastrointestinal stromal tumour is the mos, common gastrointestinal mesenchymal tumors. The gastrointestinal stromal tumour of biological characteristics is different from intestinal smooth muscle tumours and nerve sheath tumours. The result of immunohistochemical was expressed of CD117 and CD34.
出处 《新疆医科大学学报》 CAS 2009年第9期1278-1279,共2页 Journal of Xinjiang Medical University
关键词 胃肠道间质瘤 CD117 CD34 间叶源性肿瘤 gastrointestinal stromal tumour CDl17 CD34 mesenchymal tumours
  • 相关文献

参考文献3

二级参考文献16

  • 1詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 2梁玉梅,李向红,吕有勇,吕亚莉,钟梅,蒲小璐,李文梅.胃肠道间质瘤156例临床病理学特征与预后的分析[J].中华病理学杂志,2007,36(4):233-238. 被引量:15
  • 3Raut CP, Morgan JA, Ashley SW. Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol, 2007, 23(2) : 149-158.
  • 4Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal turnouts, lancet Oncol, 2002, 3 (11) : 655-664.
  • 5Fletcher CD, Berman JJ, Corless CL, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002,33 (5) :459-465.
  • 6Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med, 2006,130 (10) : 1466-1478.
  • 7DeMatteo R, Owzar K, Maki R, et al. Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase Ⅲ trial ACOSOG Z9001. J Clin Oncol, 2007, 25(18S) :10079.
  • 8Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer,2002, 38 (Suppl 5) : S39-S.51.
  • 9Parfitt JR, Streutker CJ, Riddell RH, et al. Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract, 2006, 202(12) : 837-847.
  • 10Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005,29(1) :52-68.

共引文献53

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部